Trending Now
Applied Genetic Technologies Corporation (NASDAQ: AGTC) Announce Interim Results of Ongoing...
Applied Genetic Technologies Corporation (NASDAQ: AGTC) has reported interim three-month paediatric data and further adult safety findings to almost 24 months from the ongoing...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
ADMA Biologics Inc (NASDAQ: ADMA) Announces a Presentation For ASCENIV
ADMA Biologics Inc (NASDAQ: ADMA) announced there would be a presentation on respiratory viral infections and its ASCENIV therapy. The FDA has approved ASCENIV,...
MAKE IT MODERN
LATEST REVIEWS
Mustang Bio Inc. (NASDAQ: MBIO) Updates on IND for MB-207 In...
Mustang Bio Inc. (NASDAQ: MBIO) has announced that the US FDA has imposed a hold, pending CMC (Chemistry, Manufacturing, and Controls)clearance on its investigational...
MAKE IT MODERN
PERFORMANCE TRAINING
Evogene Ltd’s (NASDAQ: EVGN) AgPlenus Ltd., Subsidy Has Announced That It Has Achieved Positive...
Evogene Ltd (NASDAQ: EVGN) subsidy, AgPlenus Ltd., recently announced positive results. The results were announced for a Proof of Concept (POC) testing of a...
Allogene Therapeutics Inc. (NASDAQ:ALLO) To Present Preliminary Data From ALLO-715 Study In Multile Myeloma...
Allogene Therapeutics Inc. (NASDAQ:ALLO) has announced that it will present preliminary data from the Phase 1 UNIVERSAL ALLO-715 trial at the 62nd Annual American...
BioNTech (NASDAQ:BNTX) Says Its COVID-19 Vaccine With Pfizer (NYSE:PFE) Will Not Be Part Of...
BioNTech (NASDAQ:BNTX) and Pfizer Inc. (NYSE:PFE) have joined other leading coronavirus vaccine developers in opting out of participation in the UK plans of testing...
Nabriva’s (NASDAQ:NBRV) XELENTA Shows Efficacy In Treating Community-Acquired Bacterial Pneumonia Patients Above 65 Years
Nabriva Therapeutics plc (NASDAQ:NBRV) has announced that XELENTA (lefamulin ) has shown significant efficacy in a posthoc analysis of LEAP 1and LEAP Phase 3...
Porch Group, Inc. (PRCH): Strong Q3 Performance Drives 55% Stock Surge Amid Strategic Wins...
Porch Group, Inc. (NASDAQ: PRCH), a comprehensive homeowners insurance and vertical software platform, experienced a remarkable 55.36% increase in its stock price,...
MAKE IT MODERN
